007460.KS

Aprogen Medicines Inc. [007460.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

007460.KS Stock Summary

Top 10 Correlated ETFs

007460.KS


Top 10 Correlated Stocks

007460.KS


In the News

007460.KS Financial details

Company Rating
Buy
Market Cap
354.75B
Income
-77.7B
Revenue
137.99B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
367
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-2.96
Forward P/E
-
PEG
-0.24
P/S
2.57
P/B
1.31
P/C
-
P/FCF
-2.56
Quick Ratio
-
Current Ratio
2.88
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-483.92
EPS next Y
-
EPS next Q
-
EPS this Y
167.16%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.8%
Revenue last 5Y
8.95%
Revenue Q/Q
-3.04%
EPS Q/Q
-27.19%
-
-
-
-
SMA20
7.82%
SMA50
-7.06%
SMA100
-18.32%
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-35%
ROC
-0.16%
Gross Margin
17%
Oper. Margin
-61%
Profit Margin
-56%
Payout
-
Shs Outstand
252.67M
Shs Float
92.42M
-
-
-
-
Target Price
-
52W Range
1207.0-6328.7344
52W High
-77.81%
52W Low
+16.32%
RSI
52.41
Rel Volume
0.53
Avg Volume
2.04M
Volume
1.09M
Perf Week
4.15%
Perf Month
10.12%
Perf Quarter
-36.31%
Perf Half Y
-29.4%
-
-
-
-
Beta
0.60797
-
-
Volatility
59.26%, 66.1%
Prev Close
0.86%
Price
1404
Change
-1.89%

007460.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
1K1.71K2.25K2.44K389.43
Net income per share
-631.71400.63-577.5-215.97-576.99
Operating cash flow per share
-29.3-24.39398.34-148.68-564.1
Free cash flow per share
-108.77-203.15343.17-185.21-687.46
Cash per share
2.36K3.82K4.2K2.76K235.89
Book value per share
3.85K5.89K5.64K5.8K1.07K
Tangible book value per share
3.84K11.23K12.13K12.12K2.22K
Share holders equity per share
3.85K5.89K5.64K5.8K1.07K
Interest debt per share
3.74K2.06K1.61K1.56K497.55
Market cap
1175.4B373.87B346.98B292.52B115.08B
Enterprise value
1284.95B387.15B336.02B309.12B162.21B
P/E ratio
-36.6120.4-10.62-23.4-0.99
Price to sales ratio
23.034.782.732.071.47
POCF ratio
-789.27-335.1115.4-33.99-1.01
PFCF ratio
-212.61-40.2317.87-27.29-0.83
P/B Ratio
6.011.391.090.870.54
PTB ratio
6.011.391.090.870.54
EV to sales
25.174.952.642.192.07
Enterprise value over EBITDA
-199.188.6633.83-48.3-2.49
EV to operating cash flow
-862.83-347.0214.91-35.92-1.43
EV to free cash flow
-232.43-41.6617.31-28.84-1.17
Earnings yield
-0.030.05-0.09-0.04-1.01
Free cash flow yield
0-0.020.06-0.04-1.2
Debt to equity
0.870.320.270.240.42
Debt to assets
0.430.130.10.10.15
Net debt to EBITDA
-16.980.3-1.1-2.59-0.72
Current ratio
1.423.195.114.372.35
Interest coverage
0.084.531.08-0.23-11.54
Income quality
0.05-0.06-0.690.690.98
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.030.030.030.37
Research and developement to revenue
0.090.020.010.010.49
Intangibles to total assets
00.01000.02
Capex to operating cash flow
2.717.33-0.140.250.22
Capex to revenue
-0.08-0.1-0.02-0.01-0.32
Capex to depreciation
-1.99-2.52-0.72-0.5-0.87
Stock based compensation to revenue
00000.01
Graham number
7.39K7.29K8.56K5.31K3.73K
ROIC
0.010.090.01-0.01-0.23
Return on tangible assets
-0.080.03-0.04-0.02-0.2
Graham Net
-1.52K1.18K1.8K872.65-301.5
Working capital
41.51B238.45B349.41B373.57B121.64B
Tangible asset value
195.42B513.89B686.3B701.3B447.58B
Net current asset value
-58.31B217.47B290.24B364.58B72.73B
Invested capital
0.870.320.270.240.42
Average receivables
00000
Average payables
1.55B824.36M1.55B1.65B3.02B
Average inventory
4.79B11.29B17.35B19.1B41.18B
Days sales outstanding
00000
Days payables outstanding
010.225.726.1621.16
Days of inventory on hand
45.2107.8668.1469.35310.76
Receivables turnover
00000
Payables turnover
035.7263.7659.2717.25
Inventory turnover
8.073.385.365.261.17
ROE
-0.160.07-0.1-0.04-0.54
Capex per share
-79.47-178.76-55.17-36.52-123.36

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
624.8530.92125.64184.310
Net income per share
3.37-132.27-93.58-149.340
Operating cash flow per share
-10.1327.91-509.78-116.910
Free cash flow per share
-19.09321.85-595.51-141.280
Cash per share
1.83K1.53K272.41235.890
Book value per share
5.09K5.49K530.311.07K0
Tangible book value per share
10.54K10.71K2.16K2.22K0
Share holders equity per share
5.09K5.49K530.311.07K0
Interest debt per share
1.17K335.19377.64460.230
Market cap
306.98B360.06B631.08B115.08B0
Enterprise value
337.07B276.22B655.97B162.21B0
P/E ratio
339.25-9.69-7.65-0.960
Price to sales ratio
7.329.6622.83.10
POCF ratio
-452.8815.64-5.62-4.890
PFCF ratio
-239.6515.94-4.81-4.050
P/B Ratio
0.90.935.40.540
PTB ratio
0.90.935.40.540
EV to sales
8.047.4123.74.370
Enterprise value over EBITDA
-186.14-78.05-31.24-12.930
EV to operating cash flow
-497.2712-5.84-6.90
EV to free cash flow
-263.1412.22-5-5.710
Earnings yield
0-0.03-0.03-0.260
Free cash flow yield
00.06-0.21-0.250
Debt to equity
0.220.050.680.420
Debt to assets
0.090.030.130.150
Net debt to EBITDA
-16.6123.69-1.19-3.760
Current ratio
5.0413.6132.352.88
Interest coverage
0-0.67-10.94-10.32-2.09
Income quality
-3-2.481.460.780
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.020.021.720.190.74
Research and developement to revenue
0.010.0300.050
Intangibles to total assets
000.020.020
Capex to operating cash flow
0.89-0.020.170.210
Capex to revenue
-0.01-0.01-0.68-0.130
Capex to depreciation
-0.66-0.46-0.98-0.670
Stock based compensation to revenue
000-0.010
Graham number
621.044.04K1.06K1.9K0
ROIC
00-0.08-0.05-0.03
Return on tangible assets
0-0.01-0.03-0.05-0.03
Graham Net
334.761.05K-148.3-301.50
Working capital
410.16B463.11B148.01B121.64B134.98B
Tangible asset value
707.48B751.86B476.68B447.58B455.79B
Net current asset value
399.43B453.67B99.27B72.73B71.16B
Invested capital
0.220.050.680.420
Average receivables
00000
Average payables
2.01B2.37B3.87B4.68B2.09B
Average inventory
22.3B24.33B42.46B60.71B30.73B
Days sales outstanding
00000
Days payables outstanding
6.017.7522.869.840
Days of inventory on hand
6675.1265.19144.570
Receivables turnover
00000
Payables turnover
14.9711.613.949.140
Inventory turnover
1.361.20.340.620
ROE
0-0.02-0.18-0.14-0.1
Capex per share
-8.99-6.06-85.73-24.370

007460.KS Frequently Asked Questions

What is Aprogen Medicines Inc. stock symbol ?

Aprogen Medicines Inc. is a KR stock and trading under the symbol 007460.KS

What is Aprogen Medicines Inc. stock quote today ?

Aprogen Medicines Inc. stock price is $1404 today.

Is Aprogen Medicines Inc. stock public?

Yes, Aprogen Medicines Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap